catalpol has been researched along with Urinary Bladder Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, M; Chen, H; Huang, Y; Jin, D; Mu, X; Xue, W; Yang, G | 1 |
1 other study(ies) available for catalpol and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; G2 Phase; Gene Expression Regulation, Neoplastic; Humans; Iridoid Glucosides; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Urinary Bladder Neoplasms | 2015 |